EBR Systems, Inc.

EBR Systems, Inc. was founded in 2003 to develop an implantable system for wireless tissue stimulation, with an initial focus on addressing well-recognized shortcomings in treating heart failure with Cardiac Resynchronization Therapy (CRT). Based on a unique concept, the proprietary WiSE Technology is designed to eliminate the need for a lead to the left ventricle in CRT and the associated complications of that lead. In the future, the company will extend this platform technology into other applications in the $11B cardiac rhythm management (CRM) market.